Incyte R&D Head Pablo Cagnoni Receives Stock Awards

What Happened

• Pablo J. Cagnoni, President and Global Head of R&D at Incyte (INCY), received equity awards on July 16, 2026. The filing reports: 13,403 restricted stock units (RSUs) granted (acquired at $0.00) and two derivative awards of 33,508 and 57,861 units (also reported at $0.00). These are compensation grants, not open-market purchases or sales.

Key Details

• Transaction date: July 16, 2026; Form 4 filed July 20, 2026 (timely).
• Reported prices: $0.00 for all grants (typical for RSU/PSU awards).
• Shares issuable after this grant: including these awards, an aggregate of 183,200 shares of common stock are issuable pursuant to previously reported unvested RSUs and earned performance stock units (per filer footnote).
• Footnotes of note:
  • F1: The 13,403 RSUs vest 25% annually over four years and settle one-for-one in common shares.
  • F3: Performance shares may pay 0–200% of each award depending on Incyte’s relative total shareholder return (TSR) over a three-year performance period; earned shares vest on the third anniversary, subject to continued service.
  • F4: Related July 16, 2026 options (if applicable) vest in 37 installments: 25% after one year, remainder monthly over three years.
• This filing reports awards (code A)—compensation-related grants—rather than purchases or sales; such grants are routine executive compensation.

Context

• RSUs and performance stock units are typical long-term incentive pay; PSUs are derivative awards whose final share payout depends on performance (here, relative TSR over three years). These awards do not represent immediate cash proceeds and are subject to vesting and performance conditions.